Process for preparing (+)- homopilopic acid

Abstract: A process for preparing (+)-homopilopic acid and the salts thereof which comprises hydrolyzing a mixture of (+)-homopilopic acid ester of the general formula (I): wherein R₁ denotes a straight or branched C₁-C₁₀ hydrocarbon, and (-)-homopilopic acid ester of the general formula (II): wherein R₂ denotes a straight or branched C₁-C₁₀ hydrocarbon, in the presence of a culture, cells, culture supernatant or treated matter of a microorganism belonging to the genus Arthrobacter , Aspergillus , Escherichia , Cunninghamella , Xanthomonas , Candida , Pseudomonas , Serratia , Cellulomonas , Nocardia , Bacillus , Brevibacterium , Flavobacterium , Mycobacterium , Rhizomucor , Rhodotorula or Rhodococcus .

Description: The present invention relates to a process for preparing (+)-homopilopic acid and the salts thereof. These compounds are useful as an intermediate for preparing (+)-pilocarpine hydrochloride which is valuable medicament for the treatment of glaucoma. Prior Art Presently, the compound (+)-pilocarpine hydrochloride of the formula(III): are obtained by extracting the leaves of Pilocarpus jaborandi plant indigenous to Brazil and other countries. Such method, however, has a problem in that the supply of naturally growing raw material is susceptible to the influence of the climate and is difficult to be provided constantly. When (+)-pilocarpine hydrochloride is prepared by synthesis, it is prepared by hydrolyzing a mixture of (+)-homopilopic acid ester and (-)-homopilopic acid ester (said mixture will be referred to as (±)-homopilopic acid ester, hereinafter) under strongly acidic conditions, optically resolving the resulting mixture of (+)-homopilopic acid of the formula(IV): and (-)-homopilopic acid of the formula(V): (said mixture will be referred to as (±)-homopilopic acid, hereinafter) using d-α-methylbenzylamine to remove (-)-homopilopic acid, and converting the (+)-homopilopic acid to (+)-pilocarpine hydrochloride(J. I. DeGraw et. al., J. Pharm. Sci., 64:1700-1701, (1975)). Problems to be solved by the Invention The hydrolysis of (+)-homopilopic acid ester under strongly acidic conditions as in the above mentioned prior art causes the cleavage of lactone ring and the yield of (+)-homopilopic acid is low. Also in the hydrolysis under alkaline conditions, lactone ring is cleaved and the yield decreases considerably. Therefore, the object of the present invention is to provide a process for preparing (+)-homopilopic acid efficiently and in high yield. Means for solving the Problem The inventors have found that (+)-homopilopic acid can be prepared efficiently and in high yield by conducting the hydrolysis under mild conditions using a microorganism or an enzyme in order to prevent the cleavage of the lactone ring. [Summary of the Invention] The present invention relates to (1) a process for preparing (+)-homopilopic acid and the salts thereof which comprises hydrolyzing (±)-homopilopic acid ester, namely a mixture of the compounds of the general formulas(I) and (II) wherein R₁ and R₂ denote straight or branched C₁-C₁₀ hydrocarbons, using a microorganism belonging to the genera Arthrobacter , Aspergillus , Escherichia , Cunninghamella , Xanthomonas , Candida , Pseudomonas , Serratia , Cellulomonas , Nocardia , Bacillus , Brevibacterium , Flavobacterium , Mycobacterium , Rhizomucor , Rhodotorula or Rhodococcus , or a treated matter thereof(Process 1). Another aspect of the invention is to provide (2) a process for preparing (+)-homopilopic acid and the salts thereof which comprises hydrolyzing (±)-homopilopic acid ester, namely a mixture of the compounds of the general formula(I) and (II) wherein R₁ and R₂ denote straight or branched C₁-C₁₀ hydrocarbons, using at least one enzyme of lipases, esterases, cholesterol esterases and lipoprotein lipases(Process 2). Futher aspect of the present invention is to provide (3) a process for preparing (+)-homopilopic acid and the salts thereof which comprises hydrolyzing a mixture of (+)-homopilopic acid ester of the general formula(I) wherein R₁ denotes straight or branched C₁-C₁₀ hydrocarbon, and (-)-homopilopic acid ester of the general formula(II) wherein R₂ denotes straight or branched C₁-C₁₀ hydrocarbon using either a hydrolase selected from the group consisting of lipases, esterases and cholesterol esterases, or a microorganism belonging to the genera Brevibacterium , Escherichia or Rhodotorula , or a treated matter thereof, recovering the unreacted (+)-homopilopic acid ester, thereafter hydrolyzing said unreacted (+)-homopilopic acid ester using either a hydrolase selected from lipases and esterases, or a microorganism belonging to the genera Aspergillus , Escherichia , Xanthomonas , Candida , Pseudomonas , Serratia , Cellulomonas , Nocardia , Bacillus , Flavobacterium , Brevibacterium , Mycobacterium , Rhizomucor or Rhodococcus , or a treated matter thereof(Process 3). Fig. 1 shows NMR spectrum of methyl ester of the product of Example 37 in CDCl₃ in the presence of 0.5 equivalent of Eu(hfc)₃. The invention will be described in detail hereinafter. Suitable R₁ and R₂ are straight or branched C₁-C₁₀ hydrocarbons, typically methyl, ethyl, isopropyl, t-butyl and octyl. Suitable microorganisms for Process 1 of the present invention are Arthrobacter globiformis IFO 12136, Aspergillus sojae IAM 2703, Aspergillus terreus IAM 2179, Escherichia coli IFO 3366, Cunninghamella echinulata IFO 4443, Xanthomonas campestris IFO 13303, Xanthomonas oryzae IFO 3510, Candida utilis IFO 4961, Pseudomonas aeruginosa IAM 1275, Serratia plymuthica JCM 1244, Cellulomonas turbata FERM P-9059, Nocardia erythropolis IAM 1484, Nocardia opaca IAM 12123, Nocardia corallina IAM 12121, Nocardia rubropertincta JCM 3204, Bacillus subtilis IFO 3108, Flavobacterium lutescens IFO 3084, Brevibacterium ketoglutaricum ATCC 15588, Mycobacterium rhodochrous IFO 13161, Rhizomucor miehei IFO 9740, Rhodococcus erythropolis IFO 12682, Rhodotorula rubra IFO 0383, and the like. Though Process 1 of the present invention may be carried out by culturing one of these microorganisms in a medium containing a (±)-homopilopic acid ester, it is preferably conducted by culturing these microorganisms in a medium containing yeast extract, peptone, glucose, mineral salts, etc., at 20-37°C for a period of 1 day to 1 week, and contacting the resultant culture, cells, the supernatant, or a treated matter thereof such as crude enzyme solution obtained by disrupting the cells in the culture, with (±)-homopilopic acid ester. For example, (+)-homopilopic acid may be obtained in an aqueous solution by adding 0.1-30%, preferably 0.5-10% by weight of (±)-homopilopic acid ester to phosphate buffer or Tris-HCl, pH 5-9 preferably pH 6.0-8.0, containing said culture, cells, the supernatant or treated matter thereof, and shaking the mixture at 20-37°C for 2 to 100 hours. The pH value of the reaction solution decreases as the hydrolysis proceeds and therefore, it is preferable to add 0.5 N sodium hydroxide, sat. sodium hydrogen carbonate or sat. sodium carbonate in order to neutralize and adjust the pH. After the reaction, (+)-homopilopic acid can be recovered and purified from the reaction mixture by conventional solvent-extraction, ion exchange chromatography, etc. Specifically, the unreacted starting esters may be removed off by extracting with diethyl ether. The pH of the remaining aqueous layer is adjusted to 2-4 with 2N HCl or 2N H₂SO₄, and NaCl is added to saturation. To this mixture, an equal volume of ethyl acetate is added, stirred vigorously and centrifuged to recover ethyl acetate layer which is then dried under reduced pressure to give raw crystals of homopilopic acid. The ratio of (+)-homopilopic acid and (-)-isomer varies from 91:9 to 25:75, depending on the type of the microorganism employed. Preferably, Rhizomucor miehei IFO 9740 is used to obtain (+)-homopilopic acid in high purity. Contaminating (-)-homopilopic acid can be eliminated by treatment with an agent conventionally used for optical resolution such as d-α-methylbenzylamine. From the (+)-homopilopic acid thus obtained, pilocarpine hydrochloride of the same nature as that of naturally occurring substance may be obtained by known methods. Typical enzymes which may be mentioned for Process 2 of the present invention include Lipase PS (Amano Pharmaceutical Co. LTD) derived from Pseudomonas sp ., Lipase (Seikagaku Kogyo Co. LTD) derived from Rhizopus delemar , Lipozyme IM 20 (Novo Nordisk Bioindustry LTD) derived from Rhizomucor miehei , Lipase B from Pseudomonas fragi and Lipase OF from from Candida cylindraceae (Meito Sangyo Co. LTD), Lipase T-01(Toyo Jozo Co. LTD) from Pseudomonas fragi , Esterase(Boehringer Mannheim) from porcine liver, Cholesterol Esterase T-18(Toyo Jozo Co. LTD) from Pseudomonas sp ., and Lipoprotein Lipase(Wako Pure Chemical Industries Co. LTD) from Pseudomonas sp . In Process 2 of the invention, the reaction is conducted by dissolving one of the above mentioned enzymes in water or other suitable buffer and contacting with (±)-homopilopic acid ester. The ratio of the enzyme, (±)-homopilopic acid ester and the solvent varies depending on the enzyme used, and usually in the range of 1: 0.5-1000: 2-1,000,000 parts by weight. Preferably the reaction is carried out by shaking at 20-37°C for 2-100 hrs. in a phosphate buffer or Tris-HCl at a pH of 5-9, preferably 6.0-8.0, whereby (+)-homopilopic acid is formed in the aqueous solution. The reaction may be accelerated by adding a surface active agent such as Tween 80 to a concentration of 0.02 to 1 % by weight. The pH value of the reaction mixture decreases as the formation of (+)-homopilopic acid proceeds and therefore, it is preferable to neutralize and adjust the pH with 0.5 N sodium hydroxide, sat. sodium hydrogen carbonate or sat. sodium carbonate. After the reaction, sodium salt of (+)-homopilopic acid can be recovered and purified from the reaction mixture in analogous way as in Process 1, by conventional solvent-extraction, ion exchange chromatography, etc. The ratio of (+)-form and (-)-form of the homopilopic acid recovered by solvent extraction ranges 84:16 to 10:90 depending on the particular enzyme used. (+)-Homopilopic acid can be obtained in best purity by using Paratase M 1000L(Novo Nordisk Bioindustry LTD). Contaminating (-)-homopilopic acid can be eliminated by treatment with an agent such as d-α-methylbenzylamine conventionally used for optical resolution. From the (+)-homopilopic acid thus obtained, (+)-pilocarpine hydrochloride of the same nature as that of natural substance may be obtained by means of known techniques (97.5 % purity). Unlike Processes 1 and 2, Process 3 of the present invention does not require the optical resolution step. Process 3 is characterized in that it avoids the complicated step of optical resolution, thus achieving improvement in the yield. Process 3 comprises the first step of selectively hydrolyzing (-)-homopilopic acid ester in (±)-homopilopic acid ester to recover (+)-homopilopic acid ester, and the second step of hydrolyzing the recovered (+)-homopilopic acid ester to give (+)-homopilopic acid. Typical enzymes which may be mentioned for the first step above are Lipase T-01 from Chromobacterium viscosum and Cholesterol Esterase T-18 from Pseudomonas sp . (Toyo Jozo Co. LTD), Lipase B (Wako Pure Chemical Industries Co. LTD) from Pseudomonas fragi , Lipase PS(Amano Pharmaceutical Co. LTD) derived from Pseudomonas sp ., Lipase(Sigma) derived from Chromobacterium viscosum , and the like. Typical microorganisms which may used in the first step include Brevibacterium ammoniagens IFO 12072, Escherichia vulneris JCM 1688, Rhodotorula rubra IFO 0893, and the like. The reaction of the first step is performed by dissolving at least one of the the above mentioned enzymes or microorganisms or the treated matters thereof in water or suitable buffer and contacting with (±)-homopilopic acid ester. The ratio of the enzyme, (±)-homopilopic acid ester and the solvent varies depending on the enzyme used, and usually in the range of 1: 0.5-1000: 2-1,000,000 parts by weight. The reaction may be accelerated by adding a surface active agent such as Tween® 80 to a concentration of 0.02 to 1 % by weight. Preferably the reaction is carried out by shaking at 20-37°C for several hours to 1 week in a phosphate buffer or Tris-HCl at a pH of 5-9, preferably 6.0-8.0, whereby (-)-homopilopic acid is formed in the aqueous layer and (+)-homopilopic acid remains in oily layer. The reaction period varies depending on the respective types and amounts of the enzyme and the starting ester, and preferably the reaction is stopped when the yield of homopilopic acid produced in the aqueous layer reached at least 50 % or more. The pH value of the reaction mixture decreases as the formation of homopilopic acid proceeds and therefore, it is preferable to adjust the pH to 6-8 with 0.5 N sodium hydroxide, sat. sodium hydrogen carbonate or sat. sodium carbonate. After the reaction, the unreacted (+)-homopilopic acid ester can be recovered using an organic solvent such as diethyl ether or ethyl acetate and then used as a starting material in the second step. Typical enzymes which may be used for the second step are Lipase(Seikagaku Kogyo Co. LTD) derived from Rhizopus delemar , Lipozyme IM 20(Novo Nordisk Bioindustry LTD) derived from Rhizomucor miehei , Lipase OF(Meito Sangyo Co. LTD) from Candida cylindraceae , Esterase(Boehringer Mannheim) from porcine liver, etc. Suitable microorganisms for the second step are Aspergillus sojae IAM 2703, Escherichia col i IFO 3366, Xanthomonas oryzae IFO 3510, Candida utilis IFO 4961, Pseudomonas aeruginosa IAM 13130, Serratia plymuthica JCM 1244, Cellulomonas turbata FERM P-9059, Nocardia erythropolis IAM 1484, Nocardia rubropertincta JCM 3204, Bacillus subtilis IFO 3108, Flavobacterium lutescens IFO 3084, Brevibacterium ketoglutaricum ATCC 15588, Mycobacterium rhodochrous IFO 13161, Rhizomucor miehei IFO 9740, Rhodococcus erythropolis IFO 12682, and the like. Though (+)-homopilopic acid can be obtained by culturing these microorganisms in a medium containing (+)-homopilopic acid ester, it is preferable to conduct the step using a culture obtained by culturing a microorganism in a medium containing yeast extract, peptone, glucose, mineral salts, and the like, at 20-37°C for a period of 1 day to 1 week, or otherwise using cells or a supernatant from the culture, or a treated matter thereof such as crude enzyme solution obtained by disrupting the cells in the culture. Namely, the reaction of the second step may be effected by dissolving or suspending at least one of the enzymes or microorganisms or a treated matter thereof in water or an appropriate buffer, and contacting the mixture with the unreacted (+) -homopilopic acid ester recovered in the first step. The ratio of the enzyme or enzymatically active substance, (±)-homopilopic acid ester and the solvent varies depending on the nature of the enzyme or microorganism used, and usually in the range of 1: 0.5-1000: 2-1,000,000 parts by weight. Preferably the reaction is carried out by shaking at 20-37°C for 1 to several hours in a phosphate buffer or Tris-HCl at a pH of 5-9 preferably 6.0-8.0, whereby (+)-homopilopic acid is formed in the aqueous solution. The reaction may be accelerated as in the first step by adding a surface active agent or by adjusting the pH value of the reaction mixture to 6-8 with alkaline solution. The completion of the reaction may be monitored by means of HPLC etc. After the reaction, sodium salt of (+)-homopilopic acid can be recovered and purified from the reaction mixture by conventional methods such as solvent-extraction and ion exchange chromatography. NMR analysis of the methyl ester of the recovered product showed no peak corresponding to (-)-homopilopic acid, indicating that substantially pure (+)-homopilopic acid was formed. From the (+)-homopilopic acid thus obtained, (+)-pilocarpine hydrochloride of the same nature as that of natural substance may be obtained by known methods. Effect of the Invention According to the present invention, the reaction is carried out using a biocatalyst such as an enzyme, a microorganism, etc., and therefore the reaction conditions are so mild that no cleavage of the lactone ring occurs and the yield of (+)-homopilopic acid is very high. Process 3 of the invention does not necessitate the optical resolution step, leading to more simple procedure and increase in the yield. Therefore, the invention contributes largely to the productivity of pilocarpine hydrochloride useful as an agent for treating glaucoma. The following non-limiting Examples further illustrate the invention. In Examples, NMR data was determined in CDCl₃ in the presence of 0.5 equivalent of Eu(hfc){tris-[3-(heptafluoropropylhydroxymethylene)-d-camphor]-europium(III)}. Following Examples 1-24 illustrate the procedure of Process 1 of the present invention. Example 1 100 ml of the medium as indicated in Table 1 was inoculated with 1 platinum loop of Nocardia rubropertincta JCM 3024 strain and cultured for 4 days at 30°C. The resultant culture was centrifuged to remove the supernatant and the pellet (216 mg cells, dry weight) was suspended in 1.9 ml of 0.1 M phosphate buffer(pH 7.0). To the suspension, 1 µl of Tween 80 and 92 µl of (±)-homopilopic acid octyl ester were added and allowed to react at 30°C for 24 hours with stirring. During the reaction, sat. sodium carbonate solution was added every 6 hours to adjust the pH to 7. After the reaction, 23 mg of crystalline homopilopic acid was obtained by solvent-extraction. The content of (+)-homopilopic acid in the product was determined by NMR spectroscopy after conversion into methyl ester thereof, and found to be 87 %, while that of (-)-homopilopic acid was 13 %. Nutrient broth 4 g Yeast extract 2 g Glucose 7.5 g (NH₄)₂SO₄ 5 g Na₂HPO₄·12H₂O 3 g KH₂PO₄ 0.3 g MgSO₄·7H₂O 0.1 g CaCl₂·2H₂O 0.05 g FeSO₄·7H₂O 0.01 g Na₂M₀O₄ 0.6mg MnSO₄·6H₂O 0.6mg ZnSO₄·7H₂O 1.2mg Dissolve in 1ℓ of water and adjust to pH 7.0. Example 2 100 ml of the medium as indicated in Table 1 was inoculated with 1 platinum loop of Escherichia coli IFO 3366 strain and cultured for 1 day at 30°C. The resultant culture was centrifuged to remove the supernatant and the pellet (220 mg in dry weight) was suspended in 1.6 ml of 0.1 M Tris(pH 8.0). To the suspension, 1 µl of Tween 80 and 75 µl of (±)-homopilopic acid ethyl ester were added and allowed to react at 30°C for 24 hours with stirring. During the reaction, sat. sodium carbonate solution was added every 6 hours to adjust the pH to 8. After the reaction, 23 mg of crystalline homopilopic acid was obtained by solvent-extraction. The content of (+)-homopilopic acid in the product was determined by NMR spectroscopy after formation of methyl ester thereof, and found to be 78 %, while that of (-)-form was 22 %. Example 3 5 ml of the medium as indicated in Table 2 was inoculated with pores of Rhizomucor miehei IFO 9740 and cultured for 3 days at 30°C. The resultant culture was transferred to 100 ml of the same medium and cultured for further 4 days at 30°C. The culture thus obtained was filtered to remove the supernatant and pellet (650 mg cells, dry weight) was suspended in 7.5 ml of 0.1 M phosphate buffer (pH 7.0). To the suspension, 3 µl of Span 80 and 200 µl of (±)-homopilopic acid ethyl ester were added and allowed to react at 30°C for 48 hours with stirring. During the reaction, sat. sodium carbonate solution was added every 6 hours to adjust the pH to 7. After the reaction, 25 mg of crystalline homopilopic acid was obtained by solvent-extraction. The content of (+)-homopilopic acid in the product was determined by NMR spectroscopy after conversion into methyl ester thereof, and found to be 91 %, while that of (-)-form was 9 %. Yeast extract 5 g Malt extract 5 g (NH₄)₂SO₄ 5 g Sucrose 10 g MgSO₄ ·7H₂O 0.1 g CaCl₂·2H₂O 0.05 g FeSO₄·7H₂O 0.01 g Dissolve in 1ℓ of water and adjust to pH 6.0. Examples 4-24 In analogous way as in Examples 1-3, (+)-homopilopic acid was prepared using various types of microorganisms. The results are shown in Table 3. Ex. No. Strain Starting Material Yield (%) Content (%) 4 Arthrobacter globiformis IFO 12136 Et 14 62 5 Aspergillus sojae IAM 2703 Me 58 52 6 Aspergillus terreus IAM 2179 Et 38 43 7 Cunninghamella echinulata IFO 4443 Et 42 35 8 Xanthomonas oryzae IFO 3510 Et 35 57 9 Xanthomonas campestris IFO 13303 Et 35 51 10 Candida utilis IFO 4961 Et 38 48 11 Pseudomonas aeruginosa IAM 1275 Et 36 77 12 Serratia plymuthica JCM 1244 Et 21 67 13 Cellulomonas turbata FERM P-9059 Et 31 53 14 Nocardia erythropolis IAM 1484 tBu 25 79 15 Nocardia opaca IAM 12123 Et 41 49 16 Nocardia corallina IAM 12121 Et 36 75 17 Nocardia rubropertincta JCM 3204 Oct 40 89 18 Bacillus subtilis IFO 3108 Et 38 79 19 Flavobacterium lutescens IFO 3084 Et 36 67 20 Brevibacterium ketoglutaricum ATCC 15588 Et 33 64 21 Mycobacterium rhodochrous IFO 13161 Et 25 71 22 Rhizomucor miehei IFO 9740 Oct 50 80 23 Rhodococcus erythropolis IFO 12682 Et 37 69 24 Rhodotorula rubra IFO 0383 iPr 65 26 Example 25 36 mg of Lipase(Seikagaku Kogyo) derived from Rhizopus delemar was suspended in 2 ml of 0.1 M phosphate buffer (pH 7.0), 1 µl of Tween 80 and 100 mg of (±)-homopilopic acid ethyl ester were added and the mixture was allowed to react at 30°C for 24 hours with stirring. During the reaction, sat. sodium carbonate solution was added every 6 hours to adjust the pH to 7. After the reaction, 19 mg of white needles of homopilopic acid was obtained by solvent-extraction (Yield, 16 %). The content of (+)-homopilopic acid in the product was determined by NMR spectroscopy after formation of methyl ester thereof, and found to be 69 %, while that of (-)-form was 31 %. Example 26 60 U of Esterase(1000 U/ml, Boehringer Mannheim) from porcine liver was suspended in 2 ml of 0.1 M phosphate buffer(pH 7.0), 1 µl of Tween 80 and 100 mg of (±)-homopilopic acid butyl ester were added and the mixture was allowed to react at 30°C for 24 hours with stirring. During the reaction, sat. sodium carbonate solution was added every 6 hours to adjust the pH to 7. After the reaction, 30 mg of crystalline homopilopic acid was obtained by solvent-extraction(Yield, 25 %). The content of (+)-homopilopic acid in the product was determined by NMR spectroscopy after formation of methyl ester thereof, and found to be 71 %, while that of (-)-form was 29 %. Examples 27-35 In analogous way as in Examples 25-26, (+)-homopilopic acid was prepared using various types of enzymes. The results are shown in Table 4. Following Examples illustrate the preparation according to Process 3 of the present invention. NMR spectrum was determined at 90 MHz, and specific rotation ([α] D ) was determined in chloroform at room temperature. Example 36 8.5 mg of Lipase B(Wako) derived from Pseudomonas fragi was suspended in 10 ml of 0.1 M phosphate buffer(pH 7.0), 4 µl of Tween 80 and 600 mg of (±)-homopilopic acid ethyl ester were added, and the mixture was allowed to react at 30°C with stirring. During the reaction, sat. sodium carbonate solution was added every 6 hours to adjust the pH to 7. After 19 hours reaction, the pH of the reaction mixture was adjusted to 8.0, 10 ml of diethyl ether was added, vigourously agitated and centrifuged to recover ether phase. This extraction procedure was repeated thrice, and from the combined ether extracts was recovered 235 mg of (+)-homopilopic acid ethyl ester. [α] D : 76.1°. Example 37 235 mg of the recovered ester as obtained in Example 36 was hydrolyzed in the presence of 3 µl of Tween 80, 150 mg of Lipase OF and 12 ml of 0.1 M phosphate buffer(pH 7.0). 127 mg of crystalline homopilopic acid was obtained by solvent-extraction. The overall yield through steps 1 and 2 of homopilopic acid was 25 %. [α] D : 79.4°. The NMR spectroscopy of the product after formation of methyl ester thereof showed substantially no signal for (-)-homopilopic acid methyl ester(Fig. 1). Example 38 A culture of Bacillus subtilis IFO 3108 was prepared. 100 ml of the medium as indicated in Table 5 was inoculated with 1 platinum loop of Bacillus subtilis IFO 3108. To elevate ester decomposing activity, soybean oil was added to a concentration of 1 %, and cultured at 30°C for 1 day. The resultant culture was centrifuged to give a pellet (360 mg cells, dry weight). Nutrient broth 4 g Yeast extract 2 g Glucose 7.5 g (NH₄)₂SO₄ 5 g Na₂HPO₄·12H₂O 3 g KH₂PO₄ 0.3 g MgSO₄·7H₂O 0.1 g CaCl₂·2H₂O 0.05 g FeSO₄·7H₂O 0.01 g Na₂M₀O₄ 0.6mg MnSO₄·6H₂O 0.6mg ZnSO₄·7H₂O 1.2mg Dissolve in 1ℓ of water and adjust to pH 7.0. Example 39 360 mg(dry weight) of the pellet of Bacillus subtilis IFO 3108 as obtained in Example 38 was suspended in 5 ml of 0.1 M phosphate buffer(pH 7.0), and 100 mg of (+)-homopilopic acid ethylester as obtained in Example 36 and 2 µl of Tween 80 were added and allowed to react with stirring at 30°C. During the reaction, sat. sodium carbonate solution was added every 6 hours to adjust the pH to 7. After 72 hours reaction, 71 mg of homopilopic acid was obtained as white needles by solvent-extraction(Yield, 84 %). [α] D : 81.2°. Example 40 A culture of Rhizomucor miehei IFO 9740 was prepared. 5 ml of the medium as indicated in Table 6 was inoculated with spores of Rhizomucor miehei IFO 9740 and cultured at 30°C for 3 days. The resultant culture was used to inoculate 100 ml of the same medium and cultured for further 4 days at 30°C. The culture was filtrated to remove the supernatant and 920 mg(dry weight) of the cells was obtained. Yeast extract 5 g Malt extract 5 g (NH₄)₂SO₄ 5 g Sucrose 10 g MgSO₄ ·7H₂O 0.1 g CaCl₂·2H₂O 0.05 g FeSO₄·7H₂O 0.01 g Dissolve in 1ℓ of water and adjust to pH 6.0. Example 41 100 mg of (+)-homopilopic acid ethylester as obtained in Example 36, 200 mg of the cultured strain of Rhizomucor miehei IFO 9740 as obtained in Example 40 and 2 µl of Tween 80 were added to 5 ml of 0.1 M phosphate buffer (pH 7.0), and allowed to react at 30°C. During the reaction, sat. sodium carbonate solution was added every 6 hours in order to adjust the pH to 7. After 68 hours reaction, 61 mg of crude crystalline homopilopic acid was obtained by solvent-extraction(Yield, 72 %). [α] D : 79.8°. NMR spectroscopy of the product after formation of methyl ester showed substantially no signal of (-)-homopilopic acid methyl ester. Examples 42-45 (+)-Homopilopic acid ester was recovered using 4 types of enzymes which selectively act on (-)-homopilopic acid ester. The reaction was conducted in 10 ml of 0.1 M phosphate buffer(pH 7.0) at 30°C. The results are shown in Table 7. Examples 46-47 (+)-Homopilopic acid ester as recovered in Example 44 was hydrolyzed using various enzymes as indicated in Table 8. The reaction was conducted in 5 ml of 0.1 M phosphate buffer(pH 7.0) at 30°C. The results are shown in Table 8. Examples 48-49 (+)-Homopilopic acid ethyl ester as recovered in Example 45 was hydrolyzed as in Examples above using various enzymes acting on (+)-homopilopic acid ester. The results are shown in Table 8. Examples 50-52 110 mg of (+)-homopilopic acid ethyl ester as recovered in Example 42 was hydrolyzed using various enzymes acting on (+)-homopilopic acid ester., The reaction was conducted in 5 ml of 0.1 M phosphate buffer(pH 7.0) at 30°C for 48 hours. The results are shown in Table 9. (Second Step, using microorganism) Ex. No. Strain Dry weight of microorganism (mg) Starting ester Yield (%) 50 Aspergillus sojae IAM 2703 32 Et 36 51 Escherichia coli IFO 3366 Et 68 52 Xanthomonas oryzae IFO 3510 42 Et 12 53 Candida utilis IFO 4961 23 Et 8 54 Pseudomonas aeruginosa IFO 13130 30 Et 10 55 Serratia plymuthica JCM 1244 13 Et 14 56 Cellulomonas turbata FERM P-9059 17 Et 60 57 Nocardia erythropolis IAM 1484 18 Et 14 58 Nocardia rubropertincta JCM 3204 43 Et 4 59 Flavobacterium hetescens IFO 3084 20 Et 29 60 Brevibacterium ketoglutaricum ATCC 15588 16 Et 59 61 Rhodococcus erythropolis IFO 12682 18 Et 33 62 Mycobacterium rhodoclass IFO 13161 6 Oct 6 Examples 53-58 (+)-Homopilopic acid ethyl ester as recovered in Example 43 was hydrolyzed as in Examples above using various enzymes. The results are shown in Table 9. Examples 59-61 (+)-Homopilopic acid ethyl ester as recovered in Example 45 was hydrolyzed as in Examples above using various enzymes. The results are shown in Table 9. Example 62 (+)-Homopilopic acid octyl ester as recovered in Example 44 was hydrolyzed as in Examples above using the enzyme as indicated in Table 9. The results are shown in Table 9. Following Examples 63-65 illustrate the preparation of the culture to be used in the first step of Process 3. Example 63 Brevibacterium ammoniagens IFO 12072 strain was cultured in 100 ml of the medium as indicated in Table 5 at 30°C for 1 day to produce 270 mg(dry weight) of the cells. Example 64 Escherichia vulneris JCM 1688 strain was cultured in 100 ml of the medium as indicated in Table 5 at 30°C for 1 day to produce 540 mg(dry weight) of the cells. Example 65 Rhodotorula rubra IFO 0893 strain was cultured in 100 ml of the medium as indicated in Table 6 at 30°C for 2 day to produce 750 mg(dry weight) of the cells. Examples 66-68 These Examples illustrate the preparation of (+)-homopilopic acid by the combination of the first step using the cells as obtained in Examples 63-65 and the second step using the recovered (+)-homopilopic acid ester and Lipase OF. The results are shown in Table 10.

Claims: A process for preparing (+)-homopilopic acid or a salt thereof which comprises hydrolyzing a mixture of (+)-homopilopic acid ester of the general formula (I): wherein R₁ denotes a straight or branched C₁-C₁₀ hydrocarbon, and (-)-homopilopic acid ester of the general formula (II): wherein R₂ denotes a straight or branched C₁-C₁₀ hydrocarbon, in the presence of a culture, cells, culture supernatant or treated matter of a microorganism belonging to the genus Arthrobacter , Aspergillus , Escherichia , Cunninghamella , Xanthomonas , Candida , Pseudomonas , Serratia , Cellulomonas , Nocardia , Bacillus , Brevibacterium , Flavobacterium , Mycobacterium , Rhizomucor , Rhodotorula or Rhodococcus . A process for preparing (+)-homopilopic acid or a salt thereof which comprises hydrolyzing a mixture of (+)-homopilopic acid ester and (-)-homopilopic acid ester as defined in claim 1 using at least one lipase, esterase, cholesterol esterase and/or lipoprotein lipase. A process according to claim 1 or 2 which further comprises recovering unreacted (+)-homopilopic acid ester and hydrolysing said unreacted (+)-homopilopic acid ester using either a lipase or an esterase, or a culture, cells, culture supernatant or treated matter of a microorganism belonging to the genus Aspergillus , Escherichia , Xanthomonas , Candida , Pseudomonas , Serratia , Cellulomonas , Nocardia , Bacillus , Flavobacterium , Brevibacterium , Mycobacterium , Rhizomucor or Rhodococcus .

Inventors: HAYASHIDA MIKIO C O MITSUI PET, HIRATSUKA JUNZOU C O MITSUI PE, KISE SHOICHI C O MITSUI PETROC, ORI AIICHIRO C O MITSUI PETROC, YAMADA HIDEAKI, HAYASHIDA, MIKIO, C/O MITSUI PETROCHEMICAL IND., HIRATSUKA, JUNZOU, C/O MITSUI PETROCHEMICAL IND., KISE, SHOICHI, C/O MITSUI PETROCHEMICAL IND. LTD., ORI, AIICHIRO, C/O MITSUI PETROCHEMICAL IND., YAMADA, HIDEAKI
Applicants: MITSUI PETROCHEMICAL IND, MITSUI PETROCHEMICAL INDUSTRIES, LTD.
Application year: 1990
Main classification: C12P41
IPC codes: C12R1, C12P41, C12P17